None listed
Conditions
Brief summary
This study will evaluate the impact of a novel question prompt list (QPL) for parents of children with attention-deficit hyperactivity disorder (ADHD) on their communication with their child’s doctor, and health outcomes such as adherence. The QPL aims to increase parent question asking and information sharing between clinicians and parents; improve parents’ ADHD knowledge across the developmental lifespan of their child; and thus improve adherence to medication in children with ADHD. A cluster randomised controlled trial will be used to evaluate the impact of the QPL. Paediatricians (n=26) will be recruited nationally; and randomly allocated to either the attention control group (whose patients will receive a published information leaflet about ADHD) or the intervention group (whose patients will receive the QPL to use with the paediatrician during the consultation). Intervention group paediatricians will “endorse” use of the QPL during the consultation. Both consultations will be audio-taped. Data will be collected from all parents/carers at four time points: a) baseline (prior to their next consultation), b) up to/approximately 7 days after the consultation when the QPL is first used, c) up to/approximately 7 days after their next consultation when the QPL is again used (about 1-6 months later), and d) 12 months after baseline.
Interventions
A cluster randomised controlled trial will be used to evaluate the impact of a novel attention-deficit hyperactivity disorder (ADHD)-specific question prompt list (QPL).
The ADHD-specific QPL, the first to be developed, addresses pertinent issues across a child’s developmental lifespan. It consists of 88 structured questions on diagnosis, understanding ADHD, treatment (medicines, psychological, alternative), healthcare team, monitoring and managing ADHD, future expectations (approaching adoles
A cluster randomised controlled trial will be used to evaluate the impact of a novel attention-deficit hyperactivity disorder (ADHD)-specific question prompt list (QPL). The ADHD-specific QPL, the first to be developed, addresses pertinent issues across a child’s developmental lifespan. It consists of 88 structured questions on diagnosis, understanding ADHD, treatment (medicines, psychological, alternative), healthcare team, monitoring and managing ADHD, future expectations (approaching adolescence, health and medicines, academic and social progress), and support and information. The questions are written in simple language. The QPL is not intended to influence prescribing practice; it is intended to be used by parents to support question asking during consultations with clinicians over the lifespan of the child’s ADHD, i.e. into adolescence and adulthood if required. The intervention group parents will be mailed a hardcopy of the ADHD-specific QPL to use at two consecutive visits to the paediatrician. The QPL will be given “extended paediatrician endorsement”. All intervention group paediatricians will be trained in “extended endorsement” of the QPL. This novel attention-deficit hyperactivity disorder (ADHD)-specific question prompt list (QPL) was developed as a result of a qualitative needs analysis [1], Delphi study [2], and user testing [3], conducted by members of the research team. 1. Ahmed R, Borst JM, Yong CW, Aslani P (2014) Do parents of children with attention-deficit/hyperactivity disorder (ADHD) receive adequate information about the disorder and its treatments? A qualitative investigation Patient Preference and Adherence 8(8):661-670. doi: 10.2147/PPA.S60164 2. Ahmed R, McCaffery KJ, Aslani P (2016) Development and validation of a question prompt list for parents of children with attention-deficit/hyperactivity disorder: a Delphi study Health Expectations 19(2):234-252. doi: 10.1111/hex.12341 3. Ahmed R, Raynor DK, McCaffery KJ, Aslani P (2014) The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorder BMJ Open 4(12):e006585. doi: 10.1136/bmjopen-2014-006585
Sponsors
Parisa Aslani
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Subject, Investigator)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Key inclusion criteria for paediatricians (including child psychiatrists) are that they: (i) are practising in private or public health settings; and (ii) manage and treat children with ADHD. Parents attending the practices of the enrolled paediatricians will be eligible to participate if they: (i) are 18 years or older; (ii) have a child (aged 3-18 years) with a recent diagnosis of ADHD (in the previous 12 months) irrespective of type of pharmacological or non-pharmacological treatment; (iii) are the primary carer of their child; and (iv) are fluent in the English language.
Exclusion criteria
Parents are not eligible for inclusion if their child has a diagnosis of autism spectrum disorder (ASD) and ADHD, as the focus of parents’ questions will likely be on ASD rather than ADHD.
Outcome results
None listed